Evidence map›Paper›PMID 38849955›Full record

ArticlePlant methods2024

Hyperspectral imaging for quantifying Magnaporthe oryzae sporulation on rice genotypes.

Angeline Wanjiku Maina, Erich-Christian Oerke

Abstract read
In one paragraph

Article in Plant methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Angeline Wanjiku MainaInstitute for Crop Science and Resource Conservation (INRES) - Plant Pathology, Rheinische Friedrich-Wilhelms University of Bonn, Bonn, Germany. wanjiku.maina@uni-bonn.de.
Erich-Christian OerkeInstitute for Crop Science and Resource Conservation (INRES) - Plant Pathology, Rheinische Friedrich-Wilhelms University of Bonn, Bonn, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrecise evaluation of fungal conidia production may facilitate studies on resistance mechanisms and plant breeding for disease resistance. In this study, hyperspectral imaging (HSI) was used to quantify the sporulation of Magnaporthe oryzae on the leaves of rice cultivars grown under controlled conditions. Three rice genotypes (CO 39, Nipponbare, IR64) differing in susceptibility to blast were inoculated with M. oryzae isolates Guy 11 and Li1497. Spectral information (450-850 nm, 140 wavebands) of typical leaf blast symptoms was recorded before and after induction of sporulation of the pathogen.

resultsM. oryzae produced more conidia on the highly susceptible genotype than on the moderately susceptible genotype, whereas the resistant genotype resulted in no sporulation. Changes in reflectance spectra recorded before and after induction of sporulation were significantly higher in genotype CO 39 than in Nipponbare. The spectral angle mapper algorithm for supervised classification allowed for the classification of blast symptom subareas and the quantification of lesion areas with M. oryzae sporulation. The correlation between the area under the difference spectrum (viz. spectral difference without and with sporulation) and the number of conidia per lesion and the number of conidia per lesion area was positive and count-based differences in rice - M. oryzae interaction could be reproduced in the spectral data.

conclusionsHSI provided a precise and objective method of assessing M. oryzae conidia production on infected rice plants, revealing differences that could not be detected visually.

Indexed as

BlastConidia productionOryza sativaPartial disease resistanceSpectral reflectance

Identifiers

PMID38849955
PMCPMC11161989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.